Phase 3

Enrolling

Phase 1

Enrolling
Breast Cancer or Endometrial Cancer
Imlunestrant
Enrolling

The safety and efficacy of the agents under investigation have not been established. There is no guarantee that the agents will receive regulatory approval and become commercially available for the uses being investigated.